Medtronic Assigned Patent for Implantable Medical Device Crosstalk Evaluation and Mitigation

By Targeted News Service

ALEXANDRIA, Va., Aug. 23 -- Medtronic, Minneapolis, has been assigned a patent (8,249,708) developed by seven co-inventors for an "implantable medical device crosstalk evaluation and mitigation." The co-inventors are Paul G. Krause, Shoreview, Minn., John E. Burnes, Coon Rapids, Minn., William T. Donofrio, Andover, Minn., David J. Peichel, Minneapolis, Gerald P. Arne, Long Lake, Minn., Xiaohong Zhou, Woodbury, Minn., and James D. Reinke, Maple Grove, Minn.The abstract of the patent published by the U.S. Patent and Trademark Office states: "Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient."

The patent application was filed on Jan. 30, 2009 (12/362,822). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,249,708.PN.&OS=PN/8,249,708&RS=PN/8,249,708

Written by Kusum Sangma; edited by Anand Kumar.

KS0823AK0823-775768